Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 29 resultados

MyoTreat: Myopia - from genes and environment to cellular responses and treatment PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 "In modern industrial societies, myopia has become an important ocular health problem of young people, due to its increased incidence and as...
2023-07-12 - 2027-11-30 | Financiado

PROTO: PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIEN... PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Osteoarthritis (OA) is the most common form of arthritis worldwide. Chronic low-grade inflammation in the articular environment causes carti...
2022-11-17 - 2027-12-31 | Financiado

HEAL: HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to... PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 HEAL will focus on general bottlenecks to induced pluripotent stem cell therapies with a particular focus on heart failure, which remains a...
2022-05-23 - 2026-02-28 | Financiado

ZOOOM: 3Os and IP awareness raising for collaborative ecosystems PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un HORIZON EUROPE: HORIZON-CL4-2021-HUMAN-01 ZOOOM aims to raise awareness on the importance of IP generation and management in collaborative innovation ecosystems which rely on three k...
2022-05-17 - 2024-09-30 | Financiado

EENINNOAUSTRIA4: Establishing Services Enhancing the Innovation Management Capacity of SMEs in the Enterprise Europe... A lack of innovation management capacity represents an important barrier to creating economic impact from innovation activities in SMEs. The...
2020-02-03 - 2021-12-31 | Financiado

EJP RD: European Joint Programme on Rare Diseases PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un H2020: H2020-SC1-BHC-2018-2020 As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profi...
2018-12-13 - 2024-08-31 | Financiado

EENINNOAUSTRIA3: Establishing Services Enhancing the Innovation Management Capacity of SMEs in the Enterprise Europe... A lack of innovation management capacity represents an important barrier to creating economic impact from innovation activities in SMEs. The...
2018-11-30 - 2019-12-31 | Financiado

PD_Pal: Palliative care in Parkinson s disease PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un H2020: H2020-SC1-BHC-2018-2020 Parkinson’s Disease (PD) is the second most common neurodegenerative disorder and is characterized in its advanced stages by motor and non-m...
2018-11-21 - 2022-12-31 | Financiado

SCORES: Self Consumption Of Renewable Energy by hybrid Storage systems PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un H2020: H2020-EEB-2016-2017 The SCORES project aims is to develop and demonstrate in the field a building energy system including new compact hybrid storage technologie...
2017-08-09 - 2022-04-30 | Financiado

EENINNOAUSTRIA2: Establishing Services Enhancing the Innovation Management Capacity of SMEs in the Enterprise Europe... A lack of innovation management capacity represents an important barrier to creating economic impact from innovation activities in SMEs. The...
2017-03-15 - 2018-12-31 | Financiado

PACE: A multicenter phase IIb study using HLA unmatched allogeneic placenta derived stromal cells PLX PAD... PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un H2020: H2020-SC1-2016-2017 PACE aims to transform the treatment of patients suffering from critical limb ischemia (CLI), a disease with high medical need, because of l...
2016-12-01 - 2021-12-31 | Financiado

MUSIC: Multisystem Cell Therapy for Improvement of Urinary Continence PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un H2020: H2020-SC1-2016-2017 "Stress Urinary Incontinence (SUI) is a disease affecting over 200 million people worldwide. It represents a condition with a prevalence of...
2016-11-29 - 2022-03-31 | Financiado

TECHNOBEAT: Tools and TECHNOlogies for Breakthrough in hEArt Therapies PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un H2020: H2020-PHC-2014-2015 Cardiovascular diseases including myocardial infarction (MI), which entails the irreversible loss of heart muscle tissue, constitute a major...
2015-12-01 - 2019-12-31 | Financiado

EENINNOAUSTRIA: Establishing Services Enhancing the Innovation Management Capacity of SMEs in the Enterprise Europe... A lack of innovation management capacity represents an important barrier to creating economic impact from innovation activities in SMEs. The...
2015-09-23 - 2016-12-31 | Financiado

SMEINNOAUSTRIA: Establishing SME Innovation Management Services in the Austrian Enterprise Europe Network The Horizon 2020 work programme names the lack of innovation management capacity as …an important barrier to creating economic impact… and...
2014-11-25 - 2014-12-31 | Financiado

PEG-ANION-NET: Proteomics Epi Genetics of Anion transport Network PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG tramitó un FP7: The aim of the proposal is to fortify and intensify the scientific exchange and connectivity between four groups - two in Europe (European c...
Financiado

KNEEMO: Prevention and personalized treatments in knee osteoarthritis an Initial Training Network PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un FP7: Knee Osteoarthritis (KOA) is the most common chronic musculoskeletal disorder, currently affecting over 8 million people within the EU, for...
Financiado

E-PREDICE: Early Prevention of Diabetes Complications in people with Hyperglycaemia in Europe "Background: A significant proportion of pre-diabetics, show macro and micro vascular complications associated with hyperglycaemia. Although...
Financiado

INMIND: Imaging of Neuroinflammation in Neurodegenerative Diseases PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un FP7: The goal of this proposal (INMiND) is to carry out collaborative research on molecular mechanisms that link neuroinflammation with neurodege...
Financiado

BETA-JUDO: Beta cell function in juvenile diabetes and obesity PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG participó en un FP7: The number of individuals with obesity and type 2 diabetes mellitus (T2DM) is increasing. An alarming aspect is decline in age of onset of T...
Financiado

PMU